Stefan Ries is a seasoned professional with over 20 years of experience in oncology drug development, including work in Big Pharma, Venture Capital, and Biotech. Currently serving as Chief Scientific Officer at CatalYm GmbH, they are focused on developing next-generation cancer immunotherapy. Previously, they held prominent roles at Roche, MediGene AG, and served as a postdoctoral fellow at the University of California, San Francisco, where they contributed to significant research in oncolytic viruses. With a PhD in Biochemistry from the University of Regensburg, Stefan is recognized for their strategic thinking and leadership in advancing scientific initiatives.
This person is not in the org chart
This person is not in any teams
This person is not in any offices